periodontitis

Otenaproxesul (ATB 346) is a novel hydrogen sulphide-releasing derivative of naproxen with markedly reduced toxicity.

ML324(IC50=920 nM) is a specific inhibitor of jumonji histone demethylase (JMJD2).

Levofloxacin hydrate (Cravit hydrate) is a broad-spectrum, third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity. Levofloxacin diffuses through the bacterial cell wall and acts by inhibiting DNA gyrase (bacterial topoisomerase II), an enzyme required for DNA replication, RNA transcription, and repair of bacterial DNA. Inhibition of DNA gyrase activity leads to blockage of bacterial cell growth.

Levofloxacin ((-)-Ofloxacin) is a synthetic fluoroquinolone antibiotic that inhibits the superhelical activity of bacterial DNA rotamase and prevents DNA replication. Levofloxacin is a broad-spectrum antibiotic used for the treatment of a wide range of bacterial infections.

Levofloxacin is a broad-spectrum, third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity. Levofloxacin diffuses through the bacterial cell wall and acts by inhibiting DNA gyrase (bacterial topoisomerase II), an enzyme required for DNA replication, RNA transcription, and repair of bacterial DNA. Inhibition of DNA gyrase activity leads to blockage of bacterial cell growth.

MEG hemisulfate (Mercaptoethylguanidine hemisulfate) acts as a highly potent and selective suppressor of inducible NO synthase (iNOS), demonstrating EC50 values of 11.5 μM for iNOS, 110 μM for ecNOS, and 60 μM for bNOS in tissue homogenates. It is notably effective as a peroxynitrite scavenger and blocks peroxynitrite-triggered oxidative mechanisms. Furthermore, this compound offers protective benefits across various experimental inflammation prototypes, such as ischemia/reperfusion injury, hemorrhagic shock, periodontitis, inflammatory bowel disease, and both endotoxic and septic shock.

Levofloxacin mesylate is an orally active antibiotic effective against both Gram-positive and Gram-negative bacteria. It inhibits DNA gyrase and topoisomerase IV enzymes. Levofloxacin mesylate is employed in research related to chronic periodontitis, airway inflammation, and BK viremia. Additionally, it possesses anti-Orthopoxvirus activity.

PROTACBTK Degrader-9 (compound 23) is a potent PROTACs degrader that specifically targets BTK. It effectively downregulates the RANKL-activated BTK-PLCγ2-Ca2+-NFATc1 signaling pathway. Consequently, PROTACBTK Degrader-9 inhibits osteoclastogenesis and reduces alveolar bone resorption in a mouse model of periodontitis.

Gala-SR is a RORα agonist that enhances the amplitude of circadian rhythms to improve rhythm disorders. It is useful for research in periodontitis.

Satranidazole is an anti-bacterial. It is used to treat periodontitis.

Fentiazac(BR-700) is an orally active nonsteroidal alkanoic acid derivative with significant analgesic, anti-inflammatory, and antipyretic activity.Fentiazac is used in the study of inflammatory diseases such as rheumatoid arthritis, osteoarthritis, periodontitis, and tendonitis.

Mollugin (Rubimaillin) may be a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway. Mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF- κ B. Mollugin may be a novel therapeutic candidate for bone loss-associated disorders including osteoporosis, rheumatoid arthritis, and periodontitis. Also, it has anticancer efficacy, can modulate the HER2 pathway in HER2-overexpressing Y cells with a potential role in the treatment and prevention of human breast and ovarian Y with HER2 overexpression.

Quebecol, a nutraceutical agent, has demonstrated efficacy against periodontitis.

AMY-101 acetate (Cp40 acetate) is a cyclic peptide, an inhibitor of C3 Complement and an immunomodulator used in the treatment of gingivitis and periodontitis, which significantly reduces inflammation and lowers MMP-8 and MMP-9 levels.AMY-101 acetate also have a palliative effect on covid -19-induced lung inflammation/injury and SARS-COV-2-related acute kidney injury in patients with acute respiratory distress syndrome (ARDS).

BML-244 is an effective inhibitor of cathepsin K. It is utilized in research related to rheumatoid arthritis and periodontitis.

Mollugin (Standard) is a reference standard for research and analysis in studies involving Mollugin. Mollugin (Rubimaillin) may be a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway. Mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF- κ B. Mollugin may be a novel therapeutic candidate for bone loss-associated disorders including osteoporosis, rheumatoid arthritis, and periodontitis. Also, it has anticancer efficacy, can modulate the HER2 pathway in HER2-overexpressing Y cells with a potential role in the treatment and prevention of human breast and ovarian Y with HER2 overexpression.

Napyradiomycin B4 is a derivative of Napyradiomycin that inhibits the RANKL-induced MEK-ERK signaling pathway. It reduces osteoclastogenesis and prevents alveolar bone destruction in experimental periodontitis.

Antcin K is a selective inhibitor that targets the PI3K/Akt, NF-κB, MEK1/2-ERK, p38, and AP-1 pathways. It enhances IL-10 expression, thereby suppressing pro-inflammatory cytokine production, blocking monocyte adhesion, reducing tissue damage, and promoting myogenesis. Antcin K exhibits significant anti-inflammatory, anti-damage, and tissue-protective activities. It is primarily studied in the context of inflammatory-related diseases such as periodontitis, rheumatoid arthritis, and skeletal muscle injury.

Epimedokoreanin B is a natural isopentenylflavonoid compound isolated from Korean horny goat weed (Epimedium koreanum Nakai) that exhibits anticancer, anti-inflammatory, and antibacterial activities. Epimedokoreanin B is an anti-periodontitis agent that inhibits the growth and biofilm formation of gingival proteases and Porphyromonas gingivalis. Epimedokoreanin B can inhibit the growth of lung cancer cells through endoplasmic reticulum stress-mediated apoptosis accompanied by autophagy.

Glycozolidal is a carbazole alkaloid isolated from the leaves or stems of Clausena lansium (Lour.) Skeels. It exhibits potent antibacterial activity against Porphyromonas gingivalis, a keystone pathogen involved in the pathogenesis of chronic periodontitis. In vitro studies have also characterized its cytotoxic profile, with IC50 values of 120.86 µg/mL against human gingival fibroblasts (HGFs) and 97.74 µg/mL against U937 monocytes. This bioactive secondary metabolite serves as a significant scaffold for exploring novel antimicrobial agents targeting oral infections and studying the structure-activity relationships of carbazole derivatives.

AMY-101 TFA is a cyclic peptide that acts as an inhibitor of complement C3 and an immunomodulator, used for the treatment of gingivitis and periodontitis. It significantly reduces inflammation and lowers levels of MMP-8 and MMP-9. AMY-101 TFA also has a mitigating effect on lung inflammation/damage in patients with COVID-19-induced ARDS and acute kidney injury associated with SARS-CoV-2.